ClinicalTrials.gg
Drug

Evobrutinib clinical trials

Also written MSC2364447C.

studies test it
20
open now
0
in phase 3
4
first study started
2015

How each study uses evobrutinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Evobrutinib
17
M2951
15

Development codes

MSC2364447C
4

Studies by the year they started

20 studies that test it; most in 2020 (4)

Studies that test evobrutinib, by start year
YearStudies
20151
20161
20173
20182
20193
20204
20212
20223
20231

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
4
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 0

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (11) · EMD Serono Research & Development Institute, Inc. (7) · Merck KGaA, Darmstadt, Germany (2)

Often tested with

Tested in the same studies.

Digoxin (1) · Metformin (1) · Rosuvastatin (1) · Sumatriptan (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses evobrutinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Codes

What other systems call evobrutinib · ClinicalTrials.gg INT001117

  • MeSH (NLM) C000632111evobrutinibOne source NLM
  • UNII (FDA) ZA45457L1KEVOBRUTINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27295200evobrutinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C141427EvobrutinibOne source FDA
  • DrugBank DB15170One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.